Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016654 |
---|---|
Receipt number | R000019332 |
Scientific Title | Time course of serum interleukin-6 concentration during longer duration polymyxin B-immobilized fiber column hemoperfusion |
Date of disclosure of the study information | 2015/03/01 |
Last modified on | 2019/05/15 12:00:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/02/27 14:20:33 | ||
2 | Update | 2015/02/27 14:28:31 | Date of disclosure of the study information |
|
3 | Update | 2015/09/02 12:02:20 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
|
4 | Update | 2015/11/25 12:28:53 | Recruitment status |
|
5 | Update | 2018/11/07 11:29:41 | Basic design Control No. of arms Interventions/Control_2 Interventions/Control_2 |
|
6 | Update | 2018/11/07 11:30:46 | Name of primary person or sponsor Organization |
|
7 | Update | 2018/11/07 11:31:27 | Recruitment status |
|
8 | Update | 2018/11/07 11:34:21 | Target sample size |
|
9 | Update | 2018/11/11 10:52:54 | Target sample size |
|
10 | Update | 2018/11/11 11:15:52 | Organization Organization Organization Category of Funding Organization |
|
11 | Update | 2019/03/02 10:47:38 | Recruitment status |
|
12 | Update | 2019/05/14 22:27:09 | Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results date posted |
|
13 | Update | 2019/05/15 11:55:40 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
14 | Update | 2019/05/15 11:58:02 | Date of IRB Last follow-up date |
|
15 | Update | 2019/05/15 11:58:02 | Date of IRB Last follow-up date |
|
16 | Update | 2019/05/15 12:00:02 | URL releasing protocol Results Results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
17 | Update | 2019/05/15 12:00:44 | URL releasing protocol |